TruScreen Group Ltd. (TRU) AI Stock Analysis

1 Followers

TruScreen Group Ltd.

(NZX:TRU)

Select Model

Rating:42Neutral

Price Target:NZD 0.01▲(11.11% Upside)

Action:initiatedcoverage

Date:10/05/26

The overall score is low primarily because TruScreen’s financial profile shows heavy and persistent losses, negative cash flows, and substantial erosion of equity, creating a high-risk foundation for shareholders. Valuation metrics are also weak, with a negative P/E and no dividend yield, offering little support beyond speculative growth expectations. Technical indicators add modest downside bias, as the price sits below key moving averages with subdued momentum and no strong signs of an imminent trend reversal.

Positive Factors

Revenue ReboundThe 58% FY2026 revenue rebound indicates renewed commercial traction for TruScreen’s screening products after prior volatility. If this higher activity level persists, it can broaden customer adoption, improve operating leverage, and provide a larger base from which the company can work toward sustainable profitability.

Negative Factors

Gross Margin CollapseThe decline to roughly 1% gross margin shows that recent revenue growth has not translated into healthy product-level economics. Unless margins recover, additional sales may contribute little toward fixed costs, development spending, or funding needs, limiting the durability and scalability of the business model.

TruScreen Group Ltd. (TRU) vs. SPDR S&P 500 ETF (SPY)

Market Cap: NZD 4.94M
Dividend Yield: ―
Average Volume (3M): 586.80K
Price to Earnings (P/E): -2.6
Beta (1Y): -0.21
Revenue Growth: 42.20%
EPS Growth: 23.68%
Country: NZ
Employees: 6
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Devices

TruScreen Group Ltd. Business Overview & Revenue Model

Company Description

TruScreen Group Limited, alongside its subsidiaries, focuses on the development, manufacturing, and global distribution of advanced systems for cancer detection. Their commercial reach extends across various international territories, including Mexic...

TruScreen Group Ltd. Financial Statement Overview

Summary

Financial performance is very weak, with volatile but generally rising revenue overshadowed by large and persistent losses, structurally negative margins, ongoing cash burn, and significant erosion of shareholder equity and assets.

Income Statement

23Negative

Balance Sheet

34Negative

Cash Flow

18Very Negative

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	2.43M	2.43M	1.71M	2.60M	1.66M	1.68M
Gross Profit	25.48K	25.48K	515.22K	1.16M	459.99K	522.74K
EBITDA	-2.64M	-2.64M	-2.12M	-2.55M	-2.51M	-7.94M
Net Income	-2.25M	-2.25M	-2.24M	-2.05M	-2.40M	-7.89M
Balance Sheet
Total Assets	3.75M	3.75M	1.85M	4.03M	3.47M	4.39M
Cash, Cash Equivalents and Short-Term Investments	1.46M	1.46M	365.47K	2.73M	2.16M	2.80M
Total Debt	200.69K	200.69K	317.37K	0	0	0
Total Liabilities	1.16M	1.16M	839.98K	798.45K	928.16K	991.89K
Stockholders Equity	2.59M	2.59M	1.01M	3.23M	2.54M	3.40M
Cash Flow
Free Cash Flow	-2.47M	-2.47M	-2.29M	-2.03M	-2.24M	-2.53M
Operating Cash Flow	-2.47M	-2.47M	-2.29M	-2.03M	-2.19M	-2.53M
Investing Cash Flow	0	0	0	0	-49.70K	-2,662
Financing Cash Flow	3.49M	3.49M	-84.40K	2.58M	1.55M	0

TruScreen Group Ltd. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

NZ:TRU against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NZ:FPH	80Outperform	NZD 28.52B	60.60	22.84%	1.48%	15.59%	23.94%
NZ:EBO	56Neutral	NZD 4.47B	16.30	7.99%	8.76%	16.36%	5.52%
NZ:AFT	54Neutral	NZD 474.03M	31.97	14.07%	0.65%	22.44%	23.14%
NZ:OCA	54Neutral	NZD 456.27M	2973.24	0.02%	―	2.52%	-99.52%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
NZ:PEB	51Neutral	NZD 341.52M	-7.18	-190.54%	―	-47.36%	-3.79%
NZ:TRU	42Neutral	NZD 8.38M	-2.58	-75.57%	―	42.20%	23.68%

* Healthcare Sector Average

Performance Comparison

NZ:TRU and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
NZ:TRU	TruScreen Group Ltd.	0.01	-0.01	-44.44%
NZ:EBO	EBOS Group Limited	21.40	-6.48	-23.24%
NZ:FPH	Fisher & Paykel Healthcare Corporation Limited	48.48	12.09	33.22%
NZ:OCA	Oceania Healthcare Ltd.	0.63	-0.19	-23.64%
NZ:PEB	Pacific Edge Limited	0.28	0.11	62.72%
NZ:AFT	AFT Pharmaceuticals Ltd.	4.52	1.34	42.36%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 05, 2026

TruScreen Group Ltd. AI Stock Analysis